Emyria Ltd (AU:EMD) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Emyria Ltd has secured $2.525 million in a placement supported by sophisticated investors to expand its mental health treatment programs, including those for PTSD and treatment-resistant depression, addressing significant unmet needs in Australia. The funds will help scale the company’s innovative treatment model, backed by a skilled clinical team and collaboration with major health payers, to improve patient access and wellbeing. Chairman Greg Hutchinson played a key role by committing $1 million of the investment.
For further insights into AU:EMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue